GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Cash Flow Reinvestment Rate
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs342.20 Million. Explore GlaxoSmithKline Pharmaceuticals Limited capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GlaxoSmithKline Pharmaceuticals Limited Cash Flow Reinvestment Rate (2005–2025)
Historical reinvestment intensity for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. Also explore GlaxoSmithKline Pharmaceuticals Limited balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year capital reinvestment analysis for GlaxoSmithKline Pharmaceuticals Limited. For live market cap and broader valuation context, see market value of GlaxoSmithKline Pharmaceuticals Limited.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | Rs688.30 Million | Rs12.90 Billion | Rs230.20 Million | ▼ -22.2% |
| 2024 | 0.07x | Rs399.33 Million | Rs5.82 Billion | Rs312.21 Million | ▼ -96.1% |
| 2023 | 1.76x | Rs8.52 Billion | Rs4.84 Billion | Rs440.40 Million | ▼ -22.8% |
| 2022 | 2.28x | Rs18.47 Billion | Rs8.11 Billion | Rs346.41 Million | ▲ +389.0% |
| 2021 | 0.47x | Rs2.69 Billion | Rs5.78 Billion | Rs442.27 Million | ▼ -7.8% |
| 2020 | 0.51x | Rs2.48 Billion | Rs4.90 Billion | Rs1.56 Billion | ▼ -35.2% |
| 2019 | 0.78x | Rs3.11 Billion | Rs3.99 Billion | Rs2.91 Billion | ▼ -49.9% |
| 2018 | 1.56x | Rs7.36 Billion | Rs4.73 Billion | Rs4.03 Billion | ▼ -52.7% |
| 2017 | 3.29x | Rs7.76 Billion | Rs2.36 Billion | Rs3.04 Billion | ▼ -42.7% |
| 2016 | 5.74x | Rs7.99 Billion | Rs1.39 Billion | Rs2.32 Billion | ▲ +494.3% |
| 2015 | 0.97x | Rs2.61 Billion | Rs2.70 Billion | Rs1.30 Billion | ▲ +160.0% |
| 2014 | 0.37x | Rs1.05 Billion | Rs2.81 Billion | Rs582.22 Million | ▲ +198.2% |
| 2013 | 0.12x | Rs390.76 Million | Rs3.14 Billion | Rs390.76 Million | ▼ -0.6% |
| 2012 | 0.13x | Rs420.95 Million | Rs3.36 Billion | Rs420.95 Million | ▲ +181.0% |
| 2011 | 0.04x | Rs213.94 Million | Rs4.79 Billion | Rs213.94 Million | ▼ -24.8% |
| 2010 | 0.06x | Rs303.67 Million | Rs5.12 Billion | Rs303.67 Million | ▼ -17.9% |
| 2009 | 0.07x | Rs238.79 Million | Rs3.30 Billion | Rs238.79 Million | ▲ +50.5% |
| 2008 | 0.05x | Rs153.26 Million | Rs3.19 Billion | Rs153.26 Million | ▼ -33.3% |
| 2007 | 0.07x | Rs186.23 Million | Rs2.59 Billion | Rs186.23 Million | ▲ +7.6% |
| 2006 | 0.07x | Rs233.91 Million | Rs3.49 Billion | Rs233.91 Million | ▲ +63.6% |
| 2005 | 0.04x | Rs93.72 Million | Rs2.29 Billion | Rs93.72 Million | — |